Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 4/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | HTR2B | P41595 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.32 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.32 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.32 |
| ▸ | KCNJ8 | Q15842 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18143633 | 0.82 | CYP2D6 (0.37) | SLC6A2SLC6A4SLC6A3ABCC9ABCC8 | |
| SCHEMBL18143632 | 0.82 | CYP2D6 (0.37) | SLC6A2SLC6A4SLC6A3ABCC9ABCC8 | |
| SCHEMBL18143634 | 0.82 | CYP2D6 (0.37) | SLC6A2SLC6A4SLC6A3ABCC9ABCC8 | |
| SCHEMBL21996099 | 0.78 | ADRA2A (0.38) | ABCC9ABCC8KCNJ11KCNJ8 | |
| SCHEMBL30138582 | 0.78 | ADRA2A (0.38) | ABCC9ABCC8KCNJ11KCNJ8 | |
| SCHEMBL23961571 | 0.78 | ADRA2A (0.38) | ABCC9ABCC8KCNJ11KCNJ8 | |
| SCHEMBL30799673 | 0.78 | ADRA2A (0.38) | ABCC9ABCC8KCNJ11KCNJ8 | |
| SCHEMBL20045619 | 0.75 | SLC9A1 (0.54) | SLC9A1HTR7 | |
| SCHEMBL20045114 | 0.75 | SLC9A1 (0.54) | SLC9A1HTR7 | |
| SCHEMBL18157863 | 0.75 | SLC9A1 (0.54) | SLC9A1HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230220427-A1 | PROCESSES RELATED TO FORMATION OF ARYLCYCLOPROPYL CARBOXYLIC ACIDS | CORTEVA AGRISCIENCE LLC (US) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230220427-A1 | PROCESSES RELATED TO FORMATION OF ARYLCYCLOPROPYL CARBOXYLIC ACIDS | DDT, PCCA, DDC | SLC9A1 4409/4885HTR2A 1825/4885HTR2C 1557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.